Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles
Source abstract
Abstract
Abstract Physiologically‐based kinetic (PBK) modeling is a valuable tool to understand the kinetics of nanoparticles (NPs) in vivo. However, estimating PBK parameters remains challenging and commonly requires animal studies. To develop predictive models to estimate PBK parameter values based on NP characteristics, a database containing PBK parameter values and corresponding NP characteristics is needed. As a first step toward this objective, this study estimates PBK parameters for gold NPs (AuNPs) and provides a comparison of two different NPs. Two animal experiments are conducted in which varying doses of AuNPs attached with polyethylene glycol (PEG) are administered intravenously to rats. The resulting Au concentrations are used to estimate PBK model parameters. The parameters are compared with PBK parameters previously estimated for poly(alkyl cyanoacrylate) NPs loaded with cabazitaxel and for LipImage 815. This study shows that a small initial database of PBK parameters collected for three NPs is already sufficient to formulate new hypotheses on NP characteristics that may be predictive of PBK parameter values. Further research should focus on developing a larger database and on developing quantitative models to predict PBK parameter values.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Safety of Substances and Products National Institute for Public Health and the Environment – RIVM Bilthoven BA 3720 The Netherlands
Center for Health Protection National Institute for Public Health and the Environment – RIVM Bilthoven BA 3720 The Netherlands
References (43)
Show source-provided references
1. 10.1016/j.matpr.2020.05.38010.1016/j.matpr.2020.05.380 ↗
2. 10.1016/j.yexmp.2008.12.00410.1016/j.yexmp.2008.12.004 ↗
3. 10.1016/j.imlet.2017.07.01510.1016/j.imlet.2017.07.015 ↗
4. 10.3109/1061186X.2015.105104910.3109/1061186X.2015.1051049 ↗
5. 10.1016/j.addr.2009.11.00210.1016/j.addr.2009.11.002 ↗
6. 10.1016/S0168-3659(99)00248-510.1016/S0168-3659(99)00248-5 ↗
7. 10.2147/IJN.S59610.2147/IJN.S596 ↗
8. 10.1039/C9NR01082C10.1039/C9NR01082C ↗
9. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
10. 10.1016/j.biomaterials.2007.12.03710.1016/j.biomaterials.2007.12.037 ↗
11. 10.2217/nnm.10.12210.2217/nnm.10.122 ↗
12. 10.1007/s13346-022-01157-y10.1007/s13346-022-01157-y ↗
13. 10.1016/j.addr.2022.11432610.1016/j.addr.2022.114326 ↗
14. 10.1016/j.taap.2010.08.02910.1016/j.taap.2010.08.029 ↗
15. 10.1021/nl052396o10.1021/nl052396o ↗
16. 10.1016/j.biomaterials.2010.01.06510.1016/j.biomaterials.2010.01.065 ↗
17. 10.1021/nn101881810.1021/nn1018818 ↗
18. 10.1186/s12989-016-0156-210.1186/s12989-016-0156-2 ↗
19. 10.1007/s13346-022-01159-w10.1007/s13346-022-01159-w ↗
20. 10.2147/IJN.S15721010.2147/IJN.S157210 ↗
21. 10.3390/pharmaceutics1104017910.3390/pharmaceutics11040179 ↗
22. 10.1016/j.taap.2019.11476510.1016/j.taap.2019.114765 ↗
23. 10.3390/pharmaceutics1402040610.3390/pharmaceutics14020406 ↗
24. Lin Z. · Nanotoxicology · 2016 · 10 · 162
25. 10.1016/j.biomaterials.2010.07.04510.1016/j.biomaterials.2010.07.045 ↗
26. 10.1039/b806051g10.1039/b806051g ↗
27. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗
28. 10.1080/08958378.2022.211559210.1080/08958378.2022.2115592 ↗
29. 10.1021/acsnano.7b0049710.1021/acsnano.7b00497 ↗
30. 10.1002/jat.72710.1002/jat.727 ↗
31. 10.3390/pharmaceutics1210094210.3390/pharmaceutics12100942 ↗
32. 10.3390/nano709028010.3390/nano7090280 ↗
33. 10.1002/smll.20190760910.1002/smll.201907609 ↗
34. 10.2147/IJN.S3611110.2147/IJN.S36111 ↗
35. 10.2147/IJN.S2853110.2147/IJN.S28531 ↗
36. Bachler G. · Int. J. Nanomedicine · 2013 · 8 · 3365
37. 10.2147/IJN.S842810.2147/IJN.S8428 ↗
38. 10.1007/s11222-011-9269-510.1007/s11222-011-9269-5 ↗
39. 10.1098/rspa.1946.005610.1098/rspa.1946.0056 ↗
40. 10.3758/s13423-016-1015-810.3758/s13423-016-1015-8 ↗
41. Core Team R. · 2021
42. Baron K. T. · 2021
43. Scheidegger A. · 2021